Nuo Therapeutics, Inc. (AURX) stock
AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.26−0.04 (-3.08%)
Close on Oct 19, 2026Market cap $60.99MP/E –Yield –
Nuo Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Nuo Therapeutics's operating margin for the twelve months ending Jun 30, 2026 was -33.3%. For fiscal 2025 it was -76.0%, against -180.0% the year before. The highest annual figure on record is -48.5% in fiscal 2011.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -76.0% | +104.1 |
| FY2024 | Dec 31, 2024 | -180.0% | +340.6 |
| FY2023 | Dec 31, 2023 | -520.6% | +2437.6 |
| FY2022 | Dec 31, 2022 | -2958.2% | −2295.2 |
| FY2019 | Dec 31, 2019 | -663.0% | −553.2 |
| FY2018 | Dec 31, 2018 | -109.8% | +2044.6 |
| FY2017 | Dec 31, 2017 | -2154.4% | −1795.4 |
| FY2015 | Dec 31, 2015 | -359.0% | −57.6 |
| FY2014 | Dec 31, 2014 | -301.4% | −145.0 |
| FY2013 | Dec 31, 2013 | -156.4% | −34.3 |
| FY2012 | Dec 31, 2012 | -122.1% | −73.6 |
| FY2011 | Dec 31, 2011 | -48.5% | +89.7 |
| FY2010 | Dec 31, 2010 | -138.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -9.4% | +83.7 |
| Q1 FY2026 | Mar 31, 2026 | -34.3% | +119.5 |
| Q4 FY2025 | Dec 31, 2025 | -52.8% | +106.5 |
| Q3 FY2025 | Sep 30, 2025 | -52.3% | +103.3 |
| Q2 FY2025 | Jun 30, 2025 | -93.1% | +55.5 |
| Q1 FY2025 | Mar 31, 2025 | -153.8% | +148.5 |
| Q4 FY2024 | Dec 31, 2024 | -159.4% | +171.6 |
| Q3 FY2024 | Sep 30, 2024 | -155.6% | +184.3 |
| Q2 FY2024 | Jun 30, 2024 | -148.6% | +588.9 |
| Q1 FY2024 | Mar 31, 2024 | -302.4% | +1097.3 |
| Q4 FY2023 | Dec 31, 2023 | -331.0% | +970.6 |
| Q3 FY2023 | Sep 30, 2023 | -340.0% | +2044.0 |
| Q2 FY2023 | Jun 30, 2023 | -737.4% | −2243.0 |
| Q1 FY2023 | Mar 31, 2023 | -1399.7% | −1332.8 |
| Q4 FY2022 | Dec 31, 2022 | -1301.6% | −413.0 |
| Q3 FY2022 | Sep 30, 2022 | -2384.0% | −824.3 |
| Q4 FY2019 | Dec 31, 2019 | 1505.6% | +1486.2 |
| Q3 FY2019 | Sep 30, 2019 | -66.8% | +91.4 |
| Q2 FY2019 | Jun 30, 2019 | -888.6% | −467.3 |
| Q1 FY2019 | Mar 31, 2019 | -1559.6% | −1142.2 |
| Q4 FY2018 | Dec 31, 2018 | 19.4% | +4355.1 |
| Q3 FY2018 | Sep 30, 2018 | -158.2% | +689.6 |
| Q2 FY2018 | Jun 30, 2018 | -421.3% | +1652.3 |
| Q1 FY2018 | Mar 31, 2018 | -417.5% | +557.9 |
| Q4 FY2017 | Dec 31, 2017 | -4335.7% | −3285.9 |
| Q3 FY2017 | Sep 30, 2017 | -847.8% | – |
| Q2 FY2017 | Jun 30, 2017 | -2073.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -975.4% | – |
| Q3 FY2016 | Sep 30, 2016 | -1049.8% | – |
See a number that looks wrong?